Thorek DLJ, Ulmert D, Diop NFM, Lupu ME, Doran MG, Huang R, Abou DS, Larson SM and Grimm J (2014) Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle. Nature Communications 5: 3097.

Thorek DJ, Riedl C, Grimm J (2014) Clinical Cerenkov luminescence imaging of 18F-FDG. JNM 55(1):95-98

Thorek DLJ, Ogirala A, Beattie BJ, Grimm J (2013). Quantitative imaging of disease signatures through radioactive decay signal conversion. Nature Medicine (19) 1345-1350

Thorek DL, Grimm J (2012. Enzymatically Activatable Diagnostic Probes. Curr Pharm Biotechnol. 13(4):523-536

Moritz F. Kircher, Sanjiv S. Gambhir, and Jan Grimm. Noninvasive cell-tracking methods. Nature Reviews Clinical Oncology 8, 677-688 (November 2011).

Kircher MF, Gambhir SS, Grimm J. Noninvasive cell-tracking methods. Nat Rev Clin Oncol. 2011 Sep 27. doi: 10.1038/nrclinonc.2011.141. [Epub ahead of print]

Ruggiero A, Holland JP, Hudolin T, Shenker L, Koulova A, Bander NH, Lewis JS, Grimm J. Targeting the Internal Epitope of Prostate-Specific Membrane Antigen with 89Zr-7E11 Immuno-PET. J Nucl Med. 2011 Sep 9. Epub ahead of print.

Grimm J and Scheinberg D (2011) Will nanotechnology influence targeted cancer therapy. Seminars in Radiation oncology Apr;21(2):80-7.

Holland JP, Normand G, Ruggiero A, Lewis SL, Grimm J (2010) Intra-operative imaging of PET radiotracers using Cerenkov luminescence emissions. Molecular Imaging (in press).

Ruggiero A, Holland JP, Lewis JS, Grimm J (2010) Cerenkov Luminescence Imaging of medical isotopes. JNM 51(7): 1123-30

Kirsch DG, Grimm J, Guimares AR, Wojtkiewicz GR, Perez BA, Santiago PM, Anthony NK, Forbes T, Dopke K, Weissleder R, Jacks T (2010) Imaging primary lung cancers in mice to study radiation biology. Int J Radiat Oncol Biol Phys15; (4): 973-977.

Santra S, Kaittanis C, Grimm J, Peres JM (2009) Drug/Dye-Loaded, Multifunctional Iron Oxide Nanoparticles for Combined Targeted Cancer Therapy and Dual Optical/MR-Imaging. Small. 2009 Apr 20;5(16):1862-1868.

Perez JM*, Grimm J*, Lee Josephson, Ralph Weissleder (2008) Integrated nanosensors to determine levels and functional activity of human teloemrase. Neoplasia 10(10):1066-72.

Grimm J, Hricak H (2008) Imaging in Urology — Looking forward. Curr Opin Urol 18(1):61-4.

Kircher M, Grimm J, Filip K. Swirski, Peter Libby, Robert E. Gerszten, Jennifer R. Allport, Ralph Weissleder (2008) Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions. Circulation 117(3):388-95.

Pittet M*, Grimm J*, Berger CR*, Tamura T, Wojtkiewicz G, Nahrendorf M, Romero P, Swiski P, Weissleder R (2007) In vivo imaging of T cell delivery to tumors after adoptive transfer therapy. Proc Nat Acad Science 104(30): 12457.

Kirsch DG, Dinulescu DM, MillerJB, Grimm J, Santiago PM, Young NP, Nielsen GP, Quade BJ, Chaber CJ, Schultz CP, Takeuchi O, Bronson RT, Crowley D, Korsmeyer SJ, Yoon SS, Hornicek FJ, Weissleder R, JacksT (2007) A Spatially- and Temporally-Restricted Mouse Model of Soft Tissue Sarcoma. Nature Medicine 13(8): 992.

Ventura A*, Kirsch DG*, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, Newman J, Reczek EE, Weissleider, R, Jacks T (2007) Restauration of p53 function leads to tumor regression in vivo. Nature 445: 661-665.

Campanella GS, Grimm J, Manice LA, Colvin RA, Medoff BD, Wojtkiewicz GR, Weissleder R, Luster AD (2006) Oligomerization of CXCL10 Is Necessary for Endothelial Cell Presentation and In Vivo Activity. J Immunol. Nov 15;177(10):6991-8.

Tannous B*, Grimm J*, Perry KF, Chen JW1, Ralph Weissleder R, Breakefield XO (2006) Metabolic biotinylation of cell surface receptors for in vivo imaging. Nature Methods 3(5): 391-396.

Rabin O, Perez JM, Grimm J, Wojtkiewicz G, Weissleder R (2006) An x-ray CT imaging agent based on long circulating bismuth sulfide nanoparticles. Nature Meaterials 5(2): 118 - 122.

Zacharakis G, Kambara H, Shih H, Ripoll J, Grimm J, Saeki Y, Weissleder R, Ntzia-christos V (2005) Volumetric tomography of fluorescent proteins through small animals in-vivo. Proc Nat Acad Science 102 (51): 18252-18257.

Grimm J*, Kirsch DG*, Windsor SD, Bender Kim CF, Santiago PM, Ntziachristos V, Jacks T, Weissleder R (2005) Use of Gene Expression Profiling to Direct In Vivo Molecular Imaging of Lung Cancer. Proc Nat Acad Science 102 (40): 14404-14409.

Montet A, Ntziachristos V, Grimm J, Weissleder R (2005) Quantitative 3D fluorescence mapping of tumors. Cancer Research 65: 6330-6336.

Grimm J, and Wunder A (2004): [Current status of molecular imaging.] Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 2004 177:326-337.

Moore A, Grimm J, B Han, P Santamaria (2004) “Tracking the recruitment of diabetogenic Cd8+ T-cells to the pancreas in real time” Diabetes 53(6):1459-66.

Wunder A, Grimm J, Müller-Ladner U (2003) “Molekulare Bildgebung bei rheumatoider Arthritis [Molecular Imaging in rheumatoid arthritis]. ” Z Rheumatol 62 (Suppl 2) II/1-II/4.

Grimm J, Potthast A, Wunder A, Moore A (2003) “Magnetic resonance imaging of the pancreas and pancreatic tumors in a mouse orthotopic model of human Cancer. ” Int J Cancer 106: 806-11.

Muller-Hulsbeck S, Dimitte DN, Jahnke T, Hedderich J, Grimm J , Heller M (2003). “[In-vitro comparison of the effectiveness of different high-speed rotatory catheters].” Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 175(3): 406-12.

Muller-Hulsbeck S, Jahnke T, Liess C, Glass C, Grimm J , Heller M (2003). “Comparison of various cerebral protection devices used for carotid artery stent placement: an in vitro experiment.” J Vasc Interv Radiol 14(5): 613-20.

Mohr A, Priebe M, Taouli B, Grimm J, Heller M , Brossmann J (2003). “Selective water excitation for faster MR imaging of articular cartilage defects: initial clinical results.” Eur Radiol 13(4): 686-9.

Grimm J, Brunn H, Heller M , Mueller-Huelsbeck S (2003). “Hemolytic effect of deformed intra-arterial stents and stent grafts in vitro.” Eur Radiol 13(6): 1333-8.

Grimm J, Jahnke T, Muhle C, Heller M , Muller-Hulsbeck S (2003). “Influence of Thrombus Age on the Mechanical Thrombectomy Efficacy of the Amplatz Thrombectomy Device In Vitro.” Cardiovasc Intervent Radiol 26(2).

Both M, Jahnke T, Reinhold-Keller E, Reuter M, Grimm J, Biederer J, Brossmann J, Gross WL, Heller M , Mueller-Huelsbeck S (2003). “Percutaneous management of occlusive arterial disease associated with vasculitis: a single center experience.” Cardiovasc Intervent Radiol 26(1): 19-26.

Oudkerk M, Torres CG, Song B, Konig M, Grimm J, Fernandez-Cuadrado J, Op de Beeck B, Marquardt M, van Dijk P , de Groot JC (2002). “Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT.” Radiology 223(2): 517-24.

Muller-Hulsbeck S, Grimm J, Leidt J , Heller M (2002). “In vitro effectiveness of mechanical thrombectomy devices for large vessel diameter and low-pressure fluid dynamic applications.” J Vasc Interv Radiol 13(8): 831-9.

Muller-Hulsbeck S, Grimm J, Liess C, Hedderich J, Bergmeyer M , Heller M (2002). “Comparison and modification of two cerebral protection devices used for carotid angioplasty: in vitro experiment.” Radiology 225(1): 289-94.

Muller-Hulsbeck S, Jahnke T, Liess C, Glass C, Paulsen F, Grimm J , Heller M (2002). “In vitro comparison of four cerebral protection filters for preventing human plaque embolization during carotid interventions.” J Endovasc Ther 9(6): 793-802.

Muller-Hulsbeck S, Walluscheck KP, Priebe M, Grimm J, Cremer J , Heller M (2002). “Experience on endothelial cell adhesion on vascular stents and stent-grafts: first in vitro results.” Invest Radiol 37(6): 314-20.

Muller-Hulsbeck S, Jahnke T, Grimm J, Behm C, Hilbert C, Frahm C, Biederer J, Brossmann J , Heller M (2002). “[Early results with a monorail-stent-balloon device for endovascular treatment of renal artery stenosis].” Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 174(3): 335- 41.

Muhle C, Brossmann J, Biederer J, Jahnke T, Grimm J , Heller M (2002). “[Alar ligaments: radiological aspects in the diagnosis of patients with whiplash injuries].” Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 174(4): 416-22.

Jahnke T, Voshage G, Muller-Hulsbeck S, Grimm J, Heller M , Brossmann J (2002). “Endovascular Placement of Self-expanding Nitinol Coil Stents for the Treatment of Femoropopliteal Obstructive Disease.” J Vasc Interv Radiol 13(3): 257-66.

Biederer J, Reuter M, Both M, Muhle C, Grimm J, Graessner J , Heller M (2002). “Analysis of artifacts and detail resolution of lung MRI with breath-hold T1-weighted gradient-echo and T2-weighted fast spin-echo sequences with respiratory triggering.” Eur Radiol 12(2): 378-84.

Biederer J, Busse I, Grimm J, Reuter M, Muhle C, Freitag S , Heller M (2002). “[Sensitivity of MRI in detecting alveolar Infiltrates: Experimental studies].” Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 174(8): 1033-9.

Priebe M, Paulsen F, Jahnke T, Grimm J, Heller M , Muller-Hulsbeck S (2001). “[Mechanical brush-catheter abrasion method for the isolation and culture of human umbilical vein endothelial cells. First in vitro results].” Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 173(10): 955- 8.

Müller-Hülsbeck S, Grimm J, Jahnke T, Häselbarth G , Heller M (2001). “Flow patterns from metallic vascular endoprostheses: in vireo results.” Eur Radiol 11: 893-901.

Müller-Hülsbeck S, Brossmann J, Jahnke T, Grimm J, Reuter M, Bewig B , Heller M (2001). “Mechanical thrombectomy of major and massive pulmonary embolism with use of the amplatz thrombectomy device.” Invest Radiol 36(6): 317-22.

Muller-Hulsbeck S, Grimm J, Leidt J, Jahnke T , Heller M (2001). “Comparison of in vitro effectiveness of mechanical thrombectomy devices.” J Vasc Interv Radiol 12(10): 1185-91.

Muhle C, Brossmann J, Biederer J, Grimm J, Mohr A , Heller M (2001). “[Value of kinematic MRI in the evaluation of patients with exacerbated pain in cervical spine motion compared with static MRI].” Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 173(2): 126-32.

Jahnke T, Link J, Muller-Hulsbeck S, Grimm J, Heller M , Brossman J (2001). “Treatment of infrapopliteal occlusive disease by high-speed rotational atherectomy: initial and mid-term results.” J Vasc Interv Radiol 12(2): 221-6.

Grimm J, Muller-Hulsbeck S, Blume J, Biederer J , Heller M (2001). “[Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].” Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 173(3): 266-72.

Grimm J, Muller-Hulsbeck S , Heller M (2001). “Comparison of the mechanical thrombectomy efficacy of the Amplatz thrombectomy device and the Cragg thrombolytic brush in vitro.” Invest Radiol 36(4): 204-9.

Grimm J, Muller-Hulsbeck S, Jahnke T, Hilbert C, Brossmann J , Heller M (2001). “Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions.” J Vasc Interv Radiol 12(8): 935-42.

Grimm J, Mueller-Huelsbeck S, Mueller M, Egbers HJ, Brinkmann G , Heller M (2001). “Evaluation of hydroxyapatite implants in vertebral bodies and extremities by contrast-enhanced magnetic resonance imaging.” Arch Orthop Trauma Surg 121(3): 158-61.

Burklein D, Lochmuller E, Kuhn V, Grimm J, Barkmann R, Muller R , Eckstein F (2001). “Correlation of thoracic and lumbar vertebral failure loads with in situ vs. ex situ dual energy X-ray absorptiometry.” J Biomech 34(5): 579-87.

Müller-Hülsbeck S, Grimm J, Jahnke T, Brossmann J, Hilbert C , Heller M (2000). “[First results after implantation of the new balloon-expanded Bridge- Stent into the iliac artery].” Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 172(10): 836- 41.

Karger N, Biederer J, Lusse S, Grimm J, Steffens J, Heller M , Gluer C (2000). “Quantitation of renal perfusion using arterial spin labeling with FAIR- UFLARE.” Magn Reson Imaging 18(6): 641-7.

Jahnke T, Brossmann J, Voshage G, Hilbert C, Muller-Hulsbeck S, Grimm J, Toellner D , Heller M (2000). “[Mid-term follow-up after placement of the new balloon-expendable VIP-stent into the iliac arteries].” Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 172(4): 381-5.

Grimm J, Karger N, Lusse S, Winoto-Morbach S, Krisch B, Muller-Hulsbeck S , Heller M (2000). “Characterization of ultrasmall magnetite [correction of paramagnetic magnetite] particles as superparamagnetic contrast agents in MRI.” Invest Radiol 35(9): 553-6.

Todriia TV, Drize NI, Chertkov IL, Grimm J , Zander A (1999). “[Telomerase activity in the mouse bone marrow and subpopulations of spleen colony-forming units].” Biull Eksp Biol Med 127(3): 311-3.

Muller-Hulsbeck S, Schwarzenberg H, Tschach T, Grimm J , Heller M (1999). “[In vitro comparison of a size 6F and 8F high-speed rotational catheter for mechanical thrombus fragmentation].” Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 170(1): 94-8.

Muller-Hulsbeck S, Bathe M, Grimm J , Heller M (1999). “Enhancement of in vitro effectiveness for hydrodynamic thrombectomy devices. Simultaneous high-pressure rt-PA application.” Invest Radiol 34(8): 536-42.

Muller-Hulsbeck S, Grimm J, Suwelack D , Heller M (1999). “Mechanical assistance for enhancement of in vitro effectiveness for hydrodynamic thrombectomy.” Invest Radiol 34(11): 669-77.

Grimm J, Zeller W , Zander AR (1998). “Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantations as a marker for GVHD.” Bone Marrow Transplant 21(1): 29-32.

Zander AR, Berger C, Kroger N, Stockshlader M, Kruger W, Horstmann M, Grimm J, Zeller W, Kabisch H, Erttmann R, Schonrock P, Kuse R, Braumann D, Illiger HJ, Fiedler W, de Witt M, Hossfeld KD , Weh HJ (1997). “High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.” Clin Cancer Res 3(12 Pt 2): 2671-5.

Stockschlader M, Hassan HT, Krog C, Kruger W, Loliger C, Horstman M, Altnoder M, Clausen J, Grimm J, Kabisch H ,

Zander A (1997). “Long-term follow-up of leukaemia patients after related cryopreserved allogeneic bone marrow transplantation.” Br J Haematol 96(2): 382-6.

Kruger W, Stockschlader M, Sobottka I, Betker R, De Wit M, Kroger N, Grimm J, Arland M, Fiedler W, Erttmann R , Zander AR (1997). “Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.” Leuk Lymphoma 24(5-6): 491-9.

Grimm J, Zeller W , Zander AR (1995). “Separation and characterization of mobilized and unmobilized peripheral blood progenitor cells by counterflow centrifugal elutriation.” Exp Hematol 23(6): 535-44.

Book Chapters

Grimm J. Combination of SPECT and CT. In: Ntziachristos V (ed) “Textbook of in-vivo imaging in vertebrates”. Willey & Sons, London (in press).

Grimm J, Hengerer A, Schultz CP, Wunder A (2005). Molecular Imaging. In: Oppelt A (ed.) Imaging systems for medical diagnostics. Publicis MCD Verlag, Erlangen (in press).

Grimm J, Heller M (2001) Radiologische Schnittbilddiagnostik in der Onkologie. In: Handbuch der onkologischen Therapie (Ed.:Bruhn), Schattauer-Verlag, submitted.

Zander A, Zeller W, Stockschläder M, Berger C, Krüger W, Grimm J, Hummel K, Lölliger C, Kühnl P, Kabisch H (1996) Mobilization of progenitor cells for autologous and allogeneic transplantation. In: Gene Technology. Stem cell and leukemia research. Zander AR, Ostertag W, Afanasiev BV, Grosveld F (eds.) Springer-Verlag Berlin Heidelberg.

Zander AR, Grimm J, Zeller W (1994) Separation of peripheral blood stem cells by counterflow centrifugal elutriation. In: Molecular Biology of Hematopoiesis Volume 3. Proceedings of the 8th Symposium on Molecular Biology of Hematopoiesis held at the Basel Convention Center(New York Medical College, Basel Switzerland, 9-13 July 1993, Intercept Ltd, Andover, UK.

Zander A, Zeller W, Stockschläder M, Berger C, Krüger W, Grimm J, Hummel K, Lölliger C, Kühnl P, Kabisch H (1996) Mobilization of progenitor cells for autologous and allogeneic transplantation. In: Gene Technology. Stem Cell and Leukemia Research. AR Zander, W Ostertag, BV Afanaiev, F Grosveld (Edits.) NATO AI Series Vol h 94. Springer-Verlag Berlin Heidelberg 1996.

Stockschläder M, Grimm J, Hassan HT, Arland M, Löliger C, Clausen J, Horstmann M, Kabisch H, Zander AR (1998) Antithymocyte Globulin as part of the pretransplant conditioning regimen may reduce transplant-related morbidity and mortality in Chronic Myelogenous Leukemia patients undergoing allogeneic bone marrow transplantation. In: Acute Leukemia VII. Experimental Approach and Novel Therpies. Hiddemann W, Büchner T, Wörmann B, Ritter J, Creutzig U, Keating M, Plunkett W (Eds.). Springer Verlag Berlin, Heidelberg, New York.